Ultragenyx record Q2 2026 revenue, narrows net loss, reaffirms full-year guidance, path to profitability
Ultragenyx posts record Q2 2026 revenue of $214 million, narrows net loss to $0.90 per share and reaffirms full-year guidance and path to profitability
Company reaffirms 2026 revenue and expense guidance and maintains 2027 profitability target.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.